Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Deficient Emotional Self-Regulation in Children with Attention Deficit Hyperactivity Disorder: Mindfulness as a Useful Treatment Modality.

Huguet A, Izaguirre Eguren J, Miguel-Ruiz D, Vall Vallés X, Alda JA.

J Dev Behav Pediatr. 2019 Jul/Aug;40(6):425-431. doi: 10.1097/DBP.0000000000000682.

PMID:
31135603
2.

Difference in Psychic Distress Lived by Parents With ADHD Children and Parents With Healthy Children: Focus on Gender Differences.

Insa I, Alda JA, Chamorro M, Espadas M, Huguet A.

J Atten Disord. 2018 Aug 2:1087054718790010. doi: 10.1177/1087054718790010. [Epub ahead of print]

PMID:
30070594
3.

One-Year Prospective Study of Liver Function Tests in Children and Adolescents on Second-Generation Antipsychotics: Is There a Link with Metabolic Syndrome?

Baeza I, de la Serna E, Calvo-Escalona R, Merchán-Naranjo J, Rodríguez-Latorre P, Martínez-Cantarero MC, Andrés P, Alda JA, Muñoz-Samons D, Ilzarbe D, Arango C, Castro-Fornieles J.

J Child Adolesc Psychopharmacol. 2018 Sep;28(7):463-473. doi: 10.1089/cap.2017.0117. Epub 2018 Jul 5.

PMID:
29975563
4.

Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain: a descriptive analysis.

Quintero J, Ramos-Quiroga JA, Sebastián JS, Montañés F, Fernández-Jaén A, Martínez-Raga J, Giral MG, Graell M, Mardomingo MJ, Soutullo C, Eiris J, Téllez M, Pamias M, Correas J, Sabaté J, García-Orti L, Alda JA.

BMC Psychiatry. 2018 Feb 8;18(1):40. doi: 10.1186/s12888-017-1581-y.

5.

The Mediterranean Diet and ADHD in Children and Adolescents.

Ríos-Hernández A, Alda JA, Farran-Codina A, Ferreira-García E, Izquierdo-Pulido M.

Pediatrics. 2017 Feb;139(2). pii: e20162027. doi: 10.1542/peds.2016-2027.

6.

Delphi Consensus on Attention Deficit Hyperactivity Disorder (ADHD): evaluation by a panel of experts.

Hervás A, de Santos T, Quintero J, Ruíz-Lázaro PM, Alda JA, Fernández-Jaén A, Ramos-Quiroga JA.

Actas Esp Psiquiatr. 2016 Nov;44(6):231-43. Epub 2016 Nov 1.

7.

Absence of Change in Corrected QT Interval in Children and Adolescents Receiving Antipsychotic Treatment: A 12 Month Study.

Alda JA, Muñoz-Samons D, Tor J, Merchán-Naranjo J, Tapia-Casellas C, Baeza I, Calvo-Escalona R, Castro-Fornieles J, Martínez-Cantarero C, Andrés-Nestares P, Fernández-Avilés F, Arango C.

J Child Adolesc Psychopharmacol. 2016 Jun;26(5):449-57. doi: 10.1089/cap.2015.0151. Epub 2016 Jan 18.

PMID:
26779966
8.

Neurological Adverse Effects of Antipsychotics in Children and Adolescents.

Garcia-Amador M, Merchán-Naranjo J, Tapia C, Moreno C, Castro-Fornieles J, Baeza I, de la Serna E, Alda JA, Muñoz D, Andrés Nestares P, Cantarero CM, Arango C.

J Clin Psychopharmacol. 2015 Dec;35(6):686-93. doi: 10.1097/JCP.0000000000000419.

PMID:
26505569
9.

Expert recommendation: contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD).

Alda JA, Soutullo C, Ramos-Quiroga JA, Quintero J, Hervás A, Hernández-Otero I, Sans-Fitó A, Cardo-Jalón EC, Fernández-Jaén A, Fernández-Pérez M, Hidalgo-Vicario MI, Eddy-Ives LS, Sánchez J.

Actas Esp Psiquiatr. 2014 Dec;42 Suppl:1-16. Epub 2014 Dec 1.

10.

Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naïve patients.

Arango C, Giráldez M, Merchán-Naranjo J, Baeza I, Castro-Fornieles J, Alda JA, Martínez-Cantarero C, Moreno C, de Andrés P, Cuerda C, de la Serna E, Correll CU, Fraguas D, Parellada M.

J Am Acad Child Adolesc Psychiatry. 2014 Nov;53(11):1179-90,1190.e1-4. doi: 10.1016/j.jaac.2014.08.009. Epub 2014 Sep 2.

PMID:
25440308
11.

Antipsychotic use in children and adolescents: a 1-year follow-up study.

Baeza I, de la Serna E, Calvo-Escalona R, Morer A, Merchán-Naranjo J, Tapia C, Martínez-Cantarero MC, Andrés P, Alda JA, Sánchez B, Arango C, Castro-Fornieles J.

J Clin Psychopharmacol. 2014 Oct;34(5):613-9. doi: 10.1097/JCP.0000000000000190.

PMID:
25154009
12.

Prognostic factors of improvement in health-related quality of life in atomoxetine-treated children and adolescents with attention-deficit/hyperactivity disorder, based on a pooled analysis.

Montoya A, Quail D, Anand E, Cardo E, Alda JA, Escobar R.

Atten Defic Hyperact Disord. 2014 Mar;6(1):25-34. doi: 10.1007/s12402-013-0119-5. Epub 2013 Oct 20.

13.

Attention-deficit hyperactivity disorder: agreement between clinical impression and the SNAP-IV screening tool.

Alda JA, Serrano-Troncoso E.

Actas Esp Psiquiatr. 2013 Mar-Apr;41(2):76-83. Epub 2013 Mar 1.

14.

Secondary effects of antipsychotic treatment in naive or quasi-naive children and adolescents: design of a follow-up protocol and baseline results.

Merchán-Naranjo J, Tapia C, Bailón C, Moreno C, Baeza I, Calvo-Escalona R, Morer A, Martínez-Cantarero C, Nestares PA, Alda JÁ, Muñoz D, Arango C.

Rev Psiquiatr Salud Ment. 2012 Oct-Dec;5(4):217-28. doi: 10.1016/j.rpsm.2012.03.006. Epub 2012 Jun 30. English, Spanish.

PMID:
23021294
15.

Association of childhood adversities with the first onset of mental disorders in Spain: results from the ESEMeD project.

Perales J, Olaya B, Fernandez A, Alonso J, Vilagut G, Forero CG, San L, Alda JA, Haro JM.

Soc Psychiatry Psychiatr Epidemiol. 2013 Mar;48(3):371-84. doi: 10.1007/s00127-012-0550-5. Epub 2012 Aug 8.

PMID:
22872358
16.

Psychometric properties of the Young Mania Rating Scale for the identification of mania symptoms in Spanish children and adolescents with attention deficit/hyperactivity disorder.

Serrano E, Ezpeleta L, Alda JA, Matalí JL, San L.

Psychopathology. 2011;44(2):125-32. doi: 10.1159/000320893. Epub 2011 Jan 12.

PMID:
21228617
17.

Changes of urine dihydroxyphenylglycol to norepinephrine ratio in children with attention-deficit hyperactivity disorder (ADHD) treated with atomoxetine.

Montoya A, Escobar R, García-Polavieja MJ, Lachno DR, Alda JÁ, Artigas J, Cardo E, García M, Gastaminza X, Gilaberte I.

J Child Neurol. 2011 Jan;26(1):31-6. doi: 10.1177/0883073810371981. Epub 2010 Jun 4.

PMID:
20525942
18.

Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.

Moreno C, Merchán-Naranjo J, Alvarez M, Baeza I, Alda JA, Martínez-Cantarero C, Parellada M, Sánchez B, de la Serna E, Giráldez M, Arango C.

Bipolar Disord. 2010 Mar;12(2):172-84. doi: 10.1111/j.1399-5618.2010.00797.x.

PMID:
20402710
19.

Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder.

Montoya A, Hervas A, Cardo E, Artigas J, Mardomingo MJ, Alda JA, Gastaminza X, García-Polavieja MJ, Gilaberte I, Escobar R.

Curr Med Res Opin. 2009 Nov;25(11):2745-54. doi: 10.1185/03007990903316152.

PMID:
19785510
20.

[Parent-child agreement in the health related quality of life (HRQOL) of children with attention-deficit/hyperactivity disorder (ADHD): a longitudinal study].

Rajmil L, Estrada MD, Herdman M, Serra-Sutton V, Tebé C, Izaguirre J, Alda JA, Alonso J, Riley AW, Forrest CB, Starfield B.

An Pediatr (Barc). 2009 Jun;70(6):553-61. doi: 10.1016/j.anpedi.2008.12.007. Epub 2009 May 7. Spanish.

21.

Malabsorption of carbohydrates and depression in children and adolescents.

Varea V, de Carpi JM, Puig C, Alda JA, Camacho E, Ormazabal A, Artuch R, Gómez L.

J Pediatr Gastroenterol Nutr. 2005 May;40(5):561-5.

PMID:
15861016
22.

Immunolocalization of NblA, a protein involved in phycobilisome turnover, during heterocyst differentiation in cyanobacteria.

de Alda JAGO, Lichtlé C, Thomas JC, Houmard J.

Microbiology. 2004 May;150(Pt 5):1377-1384. doi: 10.1099/mic.0.26992-0.

PMID:
15133099
23.

Changes in intracellular amino acids and organic acids induced by nitrogen starvation and nitrate or ammonium resupply in the cyanobacterium Phormidium laminosum.

Tapia MI, de Alda JA, Llama MJ, Serra JL.

Planta. 1996 Apr;198(4):526-531. doi: 10.1007/BF00262638. Epub 2017 Mar 18.

PMID:
28321662

Supplemental Content

Support Center